TRADE, POLICY AND REGULATIONS COMMITTEE
This committee is responsible for engagements with the relevant stakeholders on policy, trade & regulatory matters in a timely and responsive manner.
The committee enables the association keep abreast with the dynamic changes on policy, trade and regulations as they arise. It also plays a critical role in thought leadership and market intelligence around trade and industry trends.
COMMUNICATION AND PUBLIC RELATION COMMITTEE
This committee is mandated to enable KAPI to engage with the relevant healthcare stakeholders in a coherent and responsive manner presenting accurate information and building sound relationships between KAPI its collaborators and stakeholders.
The committee enables the association to inform stakeholders and the public on matters of mutual interest. It keeps the membership informed on pertinent matters concerning the industry and health sector.
It’s also responsible for shaping public discourse in line with the mandate of the association.
COMPLIANCE, LEGAL AND GOVERNANCE COMMITTEE
This committee is mandated to enable KAPI drive the promotion and embedding of ethical principles and practices in the pharmaceutical industry in Kenya in accordance with the KAPI CODE OF PRACTICE and the IFPMA guidance on good business practices.
The committee guides the association in shaping and promotion of ethical business practices in the industry.
PHARMACOVIGILANCE AND MEDICAL AFFAIRS COMMITTEE
The committee is mandated to enable KAPI engage with relevant stakeholders in championing for quality care and patient safety. This is focused on the establishment of responsive pharmacovigilance systems and quality control measures to uphold the quality of medicines, healthcare products and technologies for the realization of positive treatment outcomes for all.
The committee plays a critical role in the furtherance of the associations’ commitment to patient safety, quality care and positive health outcomes through responsible practice in the industry.
MEDICAL DEVICES AND TECHNOLOGIES COMMITTEE
The committee is mandated to guide the strategic direction and work of the association in streamlining business practices with regard to medical devices and healthcare technologies to ensure regulatory provisions are pro-business while factoring public health needs in the overall discourse.
The committee plays a guides and supports national strategies to ensure continued access to quality, effective and hi-tech medical devices, in-vitro diagnostics and technologies.